BRIEF published on 05/16/2025 at 09:38, 6 months 19 days ago H&R Holding GmbH Launches Tender Offer for H&R GmbH & Co. KGaA Shares Shareholder Approval Dividend Tender Offer H&R GmbH & Co. KGaA Nils Hansen
PRESS RELEASE published on 05/16/2025 at 09:33, 6 months 19 days ago EQS-Adhoc: H&R GmbH & Co. KGaA: Voluntary public tender offer by H&R Holding GmbH H&R GmbH & Co. KGaA has received a voluntary public tender offer from H&R Holding GmbH, offering EUR 5.00 per share in cash. The controlling shareholder is Nils Hansen Shareholders Tender Offer H&R GmbH & Co. KGaA H&R Holding GmbH Nils Hansen
BRIEF published on 05/16/2025 at 08:55, 6 months 19 days ago H&R Holding GmbH Initiates Voluntary Public Tender Offer Acquisition Shareholders Tender Offer German Securities H&R Holding
PRESS RELEASE published on 05/16/2025 at 08:50, 6 months 19 days ago EQS-WpÜG: Tender Offer / Target company: H&R GmbH & Co. KGaA; Bidder: H&R Holding GmbH H&R Holding GmbH announces voluntary tender offer to acquire H&R GmbH & Co. KGaA. Offer of EUR 5.00 per share. Bidder reserves right for off-exchange acquisitions Acquisition Voluntary Tender Offer H&R Holding GmbH Off-exchange Acquisitions EUR 5.00 Per Share
BRIEF published on 05/15/2025 at 07:35, 6 months 20 days ago H&R GmbH & Co. KGaA Confirms First Quarter 2025 Figures Financial Figures EBITDA Growth Sales Revenue Increase Q1 2025 Performance Refining Segment Impact
PRESS RELEASE published on 05/15/2025 at 07:30, 6 months 20 days ago H&R GmbH & Co. KGaA confirms preliminary figures for Q1-2025 H&R GmbH & Co. KGaA confirms slight improvements in sales revenues and earnings for Q1-2025, with segment REFINING boosting EBITDA. More details in the quarterly statement Earnings H&R GmbH & Co. KGaA Sales Revenues Quarterly Statement Q1-2025
BRIEF published on 04/30/2025 at 15:57, 7 months 4 days ago H&R GmbH & Co. KGaA Reports Slight Growth in Q1/2025 Cash Flow EBITDA Growth Segment Performance 2025 Guidance Q1/2025 Results
PRESS RELEASE published on 04/30/2025 at 15:52, 7 months 4 days ago EQS-Adhoc: H&R GmbH & Co. KGaA: Preliminary results for Q1/2025 published H&R GmbH & Co. KGaA reports improved preliminary results for Q1/2025 with EBITDA up 5% compared to previous year. Sales revenues increased by 2.6% year-over-year EBITDA Preliminary Results H&R GmbH & Co. KGaA Sales Revenues Q1/2025
BRIEF published on 04/09/2025 at 09:29, 7 months 25 days ago H&R GmbH & Co. KGaA Releases Annual and Sustainability Reports for 2024 Sustainability Report H&R KGaA Annual Report 2024 Frankfurt Exchange Climate Agreement
PRESS RELEASE published on 04/09/2025 at 09:24, 7 months 25 days ago H&R GmbH & Co. KGaA publishes Annual Report and Sustainability Report for FY 2024 H&R GmbH & Co. KGaA publishes Annual Report and Sustainability Report for FY 2024 in Salzbergen, Germany. Reports include Climate Protection Agreement assessment. Contact: Ties Kaiser Annual Report Sustainability Report H&R GmbH & Co. KGaA Salzbergen Ties Kaiser
Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 38 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 43 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
